Bacterial endotoxins enhance the factor-X activator activity of human platelets, which may contribute to thrombin generation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for endotoxin effects on platelet procoagulant activity in animal models; human studies needed before clinical relevance.
The in vitro effect of several bacterial endotoxins on human platelets was determined. Nine different endotoxins failed to induce aggregation in platelet-rich plasma (PRP) or of platelets washed by two different methods; four of them which we studied further failed to induce [14C]serotonin release in PRP. In contrast, using recently described test systems for platelet coagulant activity, all the endotoxins shortened the latent period occurring before aggregation of a mixture of washed platelets, normal serum, and CaCl2, and the clotting time of this mixture upon addition of fibrinogen. Washed platelets obtained from PRP preincubated with endotoxin had a higher platelet coagulant activity than platelets obtained from PRP preincubated with buffer. Washed platelets contribute to thrombin generation by providing factor V, a factor X activator and possibly phospholipid. Since the endotoxins did not influence the factor V activity of platelets or the platelet factor 3 activity, either in PRP or using platelets washed by albumin density gradient centrifugation, it is suggested that they enhance the factor-X activator activity of human platelets.
No takes yet. Share an insight, caveat, or question.
Semeraro et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: